India Adhesives Market Forecast & Opportunities , 2020

G l o b a l T i s s u e E n g i n e e re d M e d i c a l D ev i c e s M a r ke t Fo re c a s t & O p p o r t u n i t i e s , 2 0 2 0

P h a r m a & H e a l t h c a r e C o n s u l t a n t s

2I n d u s t r y B r i e f

Pharmaion

Global tissue engineered medical devices market is anticipated to cross US$ 26 billion by 2020

Increasing aging population, rising number of diabetic patients and various ongoing innovations to drive theglobal tissue engineered medical devices market

According to recently published Pharmaion report, Global Tissue Engineered Medical Devices MarketForecast And opportunities, 2020, global tissue engineered medical devices market is anticipated to crossUS$ 26 billion by 2020. A wide array of factors that are expected to positively influence the global tissueengineered medical devices market during forecast period include increasing aging population, ongoingtechnological advancements and growing consumer awareness. Moreover, as compared to artificial implants,tissue engineered implants offer better biocompatibility, thereby minimizing the probability of rejection ofimplant from the body.

Global tissue engineered medical devices market is also driven by the increasing prevalence diabetes andassociated diseases across the globe. Diabetes carries a high risk of cardiovascular diseases and neuropathy.Neuropathy is among the root causes of foot amputations and ulcers in the diabetic patient, and treatmentprocess in this case requires skin substitutes. Rising prevalence of diabetes and resulting increase in foot ulcersis expected to be one of the major factors responsible for the rapid growth of skin substitutes during the forecastperiod.

New product launches by existing market players as well as new entrants is expected to boost the global tissueengineered medical devices market during forecast period. North America dominated the global tissueengineered medical devices market in 2014, and is anticipated to continue its dominance through 2020 as thepercentage of geriatric population is very high in this region. Moreover, the economic stability of the region alsohelps patients to undergo expensive treatment options.

Global tissue engineered medical devices market will continue to exhibit growth during the next five years.Growing adoption of nanotechnology and 3D Bioprinting, rising application of engineered protein, and escalatingapplications of stem cells are among the major factors driving global tissue engineered medical devices market.The demand of skin substitutes is increasing at a significant pace on account of rising neuropathy cases amongdiabetics and improving efficacy of skin substitute products. said Mr. Karan Chechi, Research Director withPharmaion, a research based global pharmaceutical and healthcare consulting firm.

3S. No. Contents

1. Research Methodology

2. Analyst View

3. Tissue Engineering Overview

4. Global Tissue Engineered Medical Devices Market Outlook

4.1. Market Size & Forecast

4.1.1. By Value

4.1.2. By Volume

4.2. Market Share & Forecast

4.2.1. By Application

4.2.2. By Source

4.2.3. By Region

4.2.4. By Company

4.3. Quality Control Policies

5. Global Tissue Engineered Medical Devices Segmental Market Outlook

5.1. Global Orthopedic Tissue Engineered Medical Devices Market Outlook

5.1.1. Market Size & Forecast

5.1.1.1. By Value

5.1.1.2. By Volume

5.1.2. Market Share & Forecast

5.1.2.1. By Product Type

5.1.2.2. By Region

5.1.2.3. By Company

5.2. Global Cardiac Tissue Engineered Medical Devices Market Outlook

T a b l e o f C o n t e n t s

Pharmaion

4T a b l e o f C o n t e n t s

S. No. Contents

5.2.1. Market Share & Forecast

5.2.1.1. By Value

5.2.1.2. By Volume

5.2.2. Market Share & Forecast

5.2.2.1. By Product Type

5.2.2.2. By Region

5.2.2.3. By Company

5.3. Global Dental Tissue Engineered Medical Devices Market Outlook

5.3.1. Market Size & Forecast

5.3.1.1. By Value

5.3.1.2. By Volume

5.3.2. Market Share & Forecast

5.3.2.1. By Product Type

5.3.2.2. By Region

5.3.2.3. By Company

5.4. Global Skin Substitutes Engineered Medical Devices Market Outlook

5.4.1. Market Size & Forecast

5.4.1.1. By Value

5.4.1.2. By Volume

5.4.2. Market Share & Forecast

5.4.2.1. By Application

5.4.2.2. By Region

5.4.2.3. By Company Pharmaion

5T a b l e o f C o n t e n t s

S. No. Contents

6. Global Tissue Engineered Medical Devices Regional Market Outlook

6.1. North America Tissue Engineered Medical Devices Market Outlook

6.1.1. Market Size & Forecast

6.1.1.1. By Value

6.1.2. Market Share & Forecast

6.1.2.1. By Country

6.1.2.2. By Application

6.2. Europe Tissue Engineered Medical Devices Market Outlook

6.2.1. Market Size & Forecast

6.2.1.1. By Value

6.2.2. Market Share & Forecast

6.2.2.1. By Country

6.2.2.2. By Application

6.3. South America Tissue Engineered Medical Devices Market Outlook

6.3.1. Market Size & Forecast

6.3.1.1. By Value

6.3.2. Market Share & Forecast

6.3.2.1. By Country

6.3.2.2. By Application Pharmaion

6T a b l e o f C o n t e n t s

S. No. Contents

6.4. Asia-Pacific Tissue Engineered Medical Devices Market Outlook

6.4.1. Market Size & Forecast

6.4.1.1. By Value

6.4.2. Market Share & Forecast

6.4.2.1. By Country

6.4.2.2. By Application

6.5. Middle East & Africa Tissue Engineered Medical Devices Market Outlook

6.5.1. Market Size & Forecast

6.5.1.1. By Value

6.5.2. Market Share & Forecast

6.5.2.1. By Country

6.5.2.2. By Application

7. Market Dynamics

7.1. Drivers

7.2. Challenges

8. Market Trends & Developments

8.1. Nanotechnology in Tissue Engineering

8.2. 3D Bioprinting Advancing the Tissue Engineering

8.3. Bone Tissue Engineering Witnessing Continuous Innovation

8.4. Increasing Use of Tissue Engineered for Chronic Wound Healing

8.5. Rising Application of Engineered Protein in Tissue Engineering Pharmaion

7T a b l e o f C o n t e n t s

S. No. Contents

8.6. Tissue Engineering and Biomaterials will Revolutionize Plastic Surgery Industry

8.7. Tissue Engineering: Future of Ophthalmology

8.8. Escalating Use of Stem Cells in Tissue Engineering Research

9. Competitive Landscape

9.1. Competition Benchmarking

9.2. Company Profiles

9.2.1. Medtronic plc

9.2.2. Stryker Corporation

9.2.3. Zimmer Biomet

9.2.4. DePuy Synthes

9.2.5. Edwards Lifesciences Corporation

9.2.6. Smith & Nephew

9.2.7. Geistlich Pharma AG

9.2.8. Organogenesis Inc.

9.2.9. Institut Straumann AG

9.2.10. CryoLife, Inc.

9.2.11. Dentsply International

9.2.12. Integra LifeSciences Corporation

9.2.13. MiMedx Group, Inc.

9.2.14. St. Jude Medical, Inc.

9.2.15. B. Braun Melsungen AG

9.2.16. Wright Medical Technology, Inc. Pharmaion

8T a b l e o f C o n t e n t s

S. No. Contents

9.2.17. ACE Surgical Supply Company, Inc.

9.2.18. BioHorizons IPH, Inc.

9.2.19. Botiss Biomaterials GmbH

9.2.20. Cytograft Tissue Engineering

9.2.21. Mlnlycke Health Care

9.2.22. TEI Biosciences

10. Strategic Recommendations

11. About Us & Disclaimer

Pharmaion

9Baseline Methodology :

For the study, Pharmaion has gathered information through primary research with respondents in tissue engineered

medical devices market across the globe, followed by external validation of the information by interviewing the

users. We also gathered insights through an exhaustive search of credible paid databases and our internal

database. Our team of analysts has prudently evaluated all the collected information and presented the same in

chronological order to depict a meaningful and clear picture of tissue engineered medical devices in all the regions

across the world.

While compiling the data, we have also validated all the collected information from multiple sources and data

warehouses, in order to present the most accurate and precise information of the concerned industry. The

information has then been verified through primary research surveys with competitors to arrive at logical figures.

Sources :

Company Websites, Company Annual Reports, Government Database (American Academy of Orthopedic Surgeons,

Centers for Disease Control and Prevention, CORDIS, etc.), WHO Reports

R e s e a r c h M e t h o d o l o g y

Pharmaion

Companies Interviewed

SRI Research, Medtronic Inc., DePuy Synthes, Cryolife, Inc., Wright Medical Technology, Smith & Nephew, Ferentis

10

S a m p l e D a t a - S n a p s h o t

Pharmaion

1 23 4

57 8

9 1011 12

35

7 911

1517

1921

2325

2010 2011 2012 2013 2014 2015E2016F2017F2018F2019F2020F

Value (USD Billion) Volume (Million Units)

Global Tissue Engineered Medical Devices

Market Size, By Value (USD Billion), By Volume

(Million Units), 2010-2020F

12,000 16,4851000

10000

1990 2012

KidneyTransplantOperations

United States Demand for

Kidney Donor, 1990 & 2012

17.00% 17.10% 17.20% 17.30% 17.40% 17.50% 17.60% 17.70% 17.80% 17.90% 18.00%

3.00% 3.10% 3.20% 3.30% 3.40% 3.50% 3.60% 3.70% 3.80% 3.90% 4.00%

6.00% 6.10% 6.20% 6.30% 6.40% 6.50% 6.60% 6.70% 6.80% 6.90% 7.00%14.00%

14.10% 14.20% 14.30% 14.40% 14.50% 14.60% 14.70% 14.80% 14.90% 15.00%

55.00% 55.10% 55.20% 55.30% 55.40% 55.50% 55.60% 55.70% 55.80% 55.90% 56.00%

2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020FOthers Skin Substitute Dental

Global Tissue Engineered Medical Devices Market Share, By Application, By Value,

2010-2020F

35.00% 35.10% 35.20% 35.30% 35.40% 35.50% 35.60% 35.70% 35.80% 35.90% 36.00%

60.00% 60.10% 60.20% 60.30% 60.40% 60.50% 60.60% 60.70% 60.80% 60.90% 61.00%

2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F

Synthetic Biomaterials Natural Biomaterials

Global Tissue Engineered Medical Devices Market

Share, By Source, By Value, 2010-2020F

Medtronic plc, 10.00%

Stryker Corporation,

10.00%

Zimmer Biomet, 10.00%

Depuy Synthes, 10.00%

Edwards Lifesciences Corporation,

10.00%

Others, 10.00%

Medtronic plc,

15.00%Stryker

Corporation,

15.00%

Zimmer Biomet, 15.00%

Depuy Synthes, 15.00%

Edwards Lifescienc

es Corporati

on, 15.00%

Others, 25.00%

Global Tissue Engineered Medical Devices Market Share, By

Company, By Value, 2014 & 2020F

2014 2020F1 2

3 45

7 89 10

11 12

North America Tissue Engineered Medical

Devices Market Size, By Value (USD

Billion), 2010-2020F

United States Percentage Breakdown

of Deaths due to Cardiovascular

Disease, 2011

Coronary Heart

Disease, 10.00%

Stroke, 10.00%

High Blood Pressure, 10.00%

Heart Failure, 10.00%

Diseases of Arteries, 10.00%

Others, 10.00%

United States Prevalence of

Cardiovascular Disease in Adults above

20 years of Age, By Age, By Sex, 2015

(% of total population)

12

34

3

5

7

9

20-39 40-59 60-79 80+

Men Women

11

R e p o r t O r d e r i n g

Pharmaion

License Type Price

Single User License $4000

Single User License Print $4500

Enterprise License $8000

To View Sample OR Purchase Report

Report Name: Global Tissue Engineered Medical Devices Market

Forecast and Opportunities, 2020

Report Price

12

A b o u t U s & D i s c l a i m e r

NORTH AMERICA

Pharmaion Consultants LLC

708 3RD Avenue, 6th Floor, New York, NY,

United State, 10017

sales@pharmaion.com

+1 646 360 1656

www.pharmaion.com

About Us

Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry.

Pharmaions core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides its customerswith high value market research and advisory services that helps them identify new market opportunities, growth engines andinnovative ways to capture the market share. As a result, Pharmaions clients lead rather than follow market trends. Not bound bylegacy, Pharmaions cutting-edge research model leverages its decades of research knowledge and an increased use of technology asengines of innovation to deliver unique research value. Provided as an alternative to traditional market research, Pharmaions reportsdo not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.

Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them withcomprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industrys best-trainedindustry Analysts and Consultants, which advises and assists customers in meeting their full service market research and consultingrequirements.

Related Reports

India Stem Cells Market Forecast & Opportunities, 2020

India Infertility Treatment Market Forecast & Opportunities, 2020

Global Cervical Cancer Vaccine Market Forecast & Opportunities, 2020

Disclaimer

The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is madethat it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been obtained fromvarious sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee the accuracy, adequacy orcompleteness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information andespecially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimatesand forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for clientsinternal consumption. Usage of the same for purpose other than internal will require prior approval of Pharmaion Consultants.

ASIA PACIFIC

Pharmaion Consultants Pvt. Ltd.

A 51, Sector 57, Noida, National Capital Region,India - 201301

sales@pharmaion.com

+91 - 120 - 452 3900

www.pharmaion.com Pharmaion